“To host the upcoming ESUR18 is an honour for Greece,” says Meeting Chair, Dr. Antonia Vlahou. “A must-attend for clinicians, investigators and young scientists working in the field of urological research, the ESUR meeting encourages stimulating, interdisciplinary discussions. Its activities are organised and coordinated to motivate and maximise the potential of individual research within and outside the country, ” said Dr. Vlahou. ESUR18 will take place from 4 to 6 October at the Biomedical Research Foundation of the Academy of Athens (BRFAA) just a few minutes away from the city centre by metro.
Hot topics and scientific highlights
Tumour molecular heterogeneity, and its impact on disease diagnosis and management are some of the highlights of ESUR18. A point-counterpoint session is organised to address the heterogeneity of bladder cancer, as reflected in the presence of multiple molecular subtypes within the muscle-invasive disease. The session will include discussions about the high research activity in the field and will examine existing controversies. Pathologists, urologists and basic researchers will give their views with respect to the definition and impact of each subtype on disease management, and will aim to reach a consensus on this challenging topic.
ESUR18 will also cover personalised-medicine approaches that provide optimal treatment based on the tumour molecular profile. The topic is correlated to handling of large molecular datasets (“big data”) and extracting the associated knowledge in the form of molecular pathways and processes affected by the disease. “This opens up many opportunities to administer biology-driven markers and therapies in a personalised manner,” stated Dr. Vlahou.
Incorporating and applying promising findings into practice is another hot topic at ESUR18. “We are at that time that multiple promising biomarkers allow non-invasive detection and prognosis of urological cancers,” said Dr. Vlahou. “Leaders in their respective fields will talk about emerging therapeutic approaches based on our increasing knowledge on cancer cell behaviour, including their epigenetic reprogramming and the impact of their microenvironment (e.g. from adipocyte, immune cells and even microbiota),” Dr. Vlahou added.
ESU course: A fundamental supplement
“The inclusion of the course ‘Clinical and histopathological basics and main research questions in prostate cancer’ is a reflection of ESUR’s strong focus on educating young scientists; and the strong, multidisciplinary links with the EAU Section of Urological Pathologists (ESUP). Organised by the European School of Urology (ESU), this course shows promise as an outstanding educational activity that can provide a global view of prostate cancer research,” stated Dr. Vlahou. Sign up for this highly-informative and free ESU course. Save the time and date: from 12:00 to 14:00 on Thursday, 4 October.
Dr. Vlahou and the rest of the esteemed faculty welcome you, ESUR18 participants, to an eventful meeting in the Grecian capital.